Finnrick - Ensuring a Safer and More Transparent Supply Chain
Junli Peptide

Junli Peptide

Retatrutide

Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Junli Peptide between 7 Jan 2026 and 25 Mar 2026. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).

Finnrick Rating™
Junli Peptide
Retatrutide
Tested 6 Samples
Last test 25 Mar 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Retatrutide tests from Junli Peptide

Samples are tested in commercial labs

Tests Count

6

Scores

AVG7.2MIN4.3MAX10.0

Last

25 Mar 2026

First

7 Jan 2026
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityEndotoxinsBatch IDContainerTested AtSent By
25 Mar 2026View6.310mg12mg+20.0%99.60%n/aJan 5, 2026 Silver Label / Silver Crimp / Clear Blue CapLab GPublic
25 Mar 2026View9.415mg15.8mg+5.3%99.70%n/aJan 5, 2026 Silver Label / Copper Crimp / Clear CapLab GPublic
16 Mar 2026View10.020mg19mg-5.0%99.90%
below LOQ
Feb 3, 2026 White Label / Silver Crimp / Violet CapLab EPublic
22 Jan 2026View4.35mg4.1mg-18.0%99.50%n/a(no batch ID)No Label / Silver Crimp / Blue CapLab GPublic
7 Jan 2026View7.720mg21.2mg+6.0%99.93%n/a(no batch ID)No Label / Silver Crimp / Violet CapLab EPublic
7 Jan 2026View5.815mg16.6mg+10.7%99.70%n/a(no batch ID)No Label / Silver Crimp / Red CapLab GPublic